Looking to balance out your exposure to DBVT? The ETFs below have historically moved differently from DBVT, which may reduce portfolio volatility when combined in a suitable allocation. The stock ideas table highlights individual companies with the same low-correlation characteristics. Correlation can change and does not guarantee that one asset will rise when another falls.
Best Diversifiers for DBVT
1 ETFs have low correlation with DBVT (below 0.3), 0 of which are negatively correlated. The least correlated is Vanguard S&P 500 ETF (VOO) (S&P 500) with a 1Y correlation of 0.23, roughly unchanged from 0.18 over 5 years.
How candidates are selected| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Category | Compare |
|---|---|---|---|---|---|---|---|
| Vanguard S&P 500 ETF | 0.23 | 0.15 | 0.18 | 78 | S&P 500 | DBVT vs VOO |
Low-Correlation Stock Ideas
The table shows companies with at least $1B in market capitalization, historical correlation data for DBVT, and a Risk / Return Rank of 50 or higher. Treat them as research candidates rather than evidence that they will offset a future decline. The least correlated is Trevi Therapeutics, Inc. (TRVI) (Healthcare) with a 1Y correlation of 0.18, roughly unchanged from 0.10 over 5 years.
How candidates are selected| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Sector |
|---|---|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 0.18 | 0.08 | 0.10 | 92 | Healthcare | |
| Palvella Therapeutics, Inc | 0.25 | — | — | 96 | Healthcare |
Build a portfolio that complements DBVT
Add DBVT to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
Analyze a portfolio with DBVT